Tuesday, January 23, 2018

Cancer drugs get fast study

A bold new way to test cancer drugs started Monday in hundreds of hospitals around the U.S. In a medical version of speed dating, doctors will sort through multiple experimental drugs and match patients to the one most likely to succeed based on each person's unique tumor gene profile.

It's an experiment that brings together drug companies, the government, private foundations and advocacy groups. The idea came from the Food and Drug Administration, which has agreed to consider approving new medicines based on the study.

Its goal is to speed new treatments to market and give seriously ill patients more chances to find something that will help. Instead of being tested for individual genes and trying to qualify for separate clinical trials testing single drugs, patients can enroll in this umbrella study, get full gene testing and have access to many options at once.

The study, called Lung-MAP, is for advanced cases of a common, hard-to-treat form of lung cancer — squamous cell. Plans for similar studies for breast and colon cancer are in the works.

"For patients, it gives them their best chance for treatment of a deadly disease," because everyone gets some type of therapy, said Ellen Sigal, chairwoman and founder of Friends of Cancer Research, a research and advocacy group that helped plan the study. "There's something for everyone, and we'll get answers faster" on whether experimental drugs work, she said.

Cancer medicines increasingly target specific gene mutations that are carried by smaller groups of patients. But researchers sometimes have to screen hundreds of patients to find a few with the right mutation, slowing down drug development.

One of the leaders of the Lung-MAP study — Dr. Roy Herbst, chief of medical oncology at the Yale Cancer Center — said he once screened 100 patients to find five that might be eligible for a study, and ultimately was able to enroll two. Up to 1,000 patients a year can be enrolled in the new study.

"Nothing like this has ever been done before," where such comprehensive testing will be done to match patients to experimental drugs, Herbst said.

Breyan Harris, a 33-year-old nurse from Sacramento, hopes to enroll. She's a lifelong non-smoker who was diagnosed with lung cancer on June 3.

"Since then I've pretty much been on the phone, seeing doctors, trying to figure out how do I get rid of this," she said. Harris expects to have one lung removed, "but if it comes back in my other lung I'm in real trouble," so finding a drug to attack any remaining, hidden cancer is crucial, she said.

Comments
After girl's killing, Pakistani women speak out on abuse

After girl's killing, Pakistani women speak out on abuse

Brutal rape, killing of 7-year-old girl whose body was left in a garbage dump unleashes revulsion around Pakistan
Updated: 10 minutes ago
After girl's killing, Pakistani women speak out on abuse

After girl's killing, Pakistani women speak out on abuse

Brutal rape, killing of 7-year-old girl whose body was left in a garbage dump unleashes revulsion around Pakistan
Updated: 10 minutes ago

AP Top News at 9:18 a.m. EST

AP Top News at 9:18 a.m. EST
Updated: 11 minutes ago

Box office totals for best picture Academy Awards nominees

Box office totals for best picture Academy Awards nominees
Updated: 11 minutes ago
US, others launch new tool to punish chemical weapons users

US, others launch new tool to punish chemical weapons users

The United States and 28 other countries have launched a new plan to identify and punish anyone who uses chemical weapons, amid new reports of a suspected chemical attack in Syria
Updated: 12 minutes ago
US, others launch new tool to punish chemical weapons users

US, others launch new tool to punish chemical weapons users

The United States and 28 other countries have launched a new plan to identify and punish anyone who uses chemical weapons, amid new reports of a suspected chemical attack in Syria
Updated: 12 minutes ago

Troubled French nuclear producer relaunches with new name

France's influential but troubled nuclear company Areva is seeking a new start with a new name
Updated: 13 minutes ago
South African jazz musician Hugh Masekela dies at 78

South African jazz musician Hugh Masekela dies at 78

South African jazz trumpeter and anti-apartheid activist Hugh Masekela dies at 78
Updated: 13 minutes ago
Del Toro’s ‘Shape of Water’ lands a leading 13 Oscar nominations

Del Toro’s ‘Shape of Water’ lands a leading 13 Oscar nominations

NEW YORK — Guillermo del Toro’s lavish monster romance "The Shape of Water" fished out a leading 13 nominations, Greta Gerwig became just the fifth woman nominated for best director and "Mudbound" cinematographer Rachel Morrison made history as the f...
Updated: 19 minutes ago

Nationalists to chair budget committee in German parliament

Nationalist Alternative for Germany party says one of its lawmakers will chair the parliamentary budget committee
Updated: 19 minutes ago